Blood Stem-Cell Transplant Regimen Reverses Sickle Cell Disease in Adults – 2
Narrator: This is NIH Health Matters. A blood stem-cell transplant regimen has effectively reversed sickle cell disease in adult patients according to a recent study. Dr. John Tisdale is the study’s principal investigator in the NIH Molecular and Clinical Hematology Branch.
Dr. Tisdale: This is a study where we were looking to see if we could fix this disease, sickle cell disease by getting bone marrow stem cells—those are the seeds of the bone marrow that all the blood comes from—from a brother or sister who doesn't have the disease and administer those to the patient with the disease as a way to replace their red blood cells.
Narrator: For more information on sickle cell disease and this discovery, visit www.niddk.nih.gov. Health Matters is produced by the National Institutes of Health, part of the U.S Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.